Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Clinical trial NCT07228832 · RECRUITING
Trial details
- NCT number
- NCT07228832
- Sponsor
- Summit Therapeutics
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-18
- Primary completion
- 2028-05-31
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.